Pediatric Radiology

, Volume 43, Issue 4, pp 406-417

First online:

FDG PET/CT in children and adolescents with lymphoma

  • Regine KlugeAffiliated withDepartment of Nuclear Medicine, University Hospital Leipzig Email author 
  • , Lars KurchAffiliated withDepartment of Nuclear Medicine, University Hospital Leipzig
  • , Françoise MontraversAffiliated withDepartment of Nuclear Medicine, Hospital Tenon
  • , Christine Mauz-KörholzAffiliated withDepartment of Paediatrics, University Hospital Halle

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The aim of this review is to give an overview of FDG PET/CT applications in children and adolescents with lymphoma. Today, FDG PET is used for tailoring treatment intensity in children with Hodgkin lymphoma within the framework of international treatment optimisation protocols. In contrast, the role of this method in children with Non-Hodgkin lymphoma is not well defined. This paper overviews clinical appearance and metabolic behaviour of the most frequent lymphoma subtypes in childhood. The main focus of the review is to summarise knowledge about the role of FDG PET/CT for initial staging and early response assessment.


FDG PET Hodgkin lymphoma Non-Hodgkin lymphoma